Medifast, Inc.
MED
$13.75
-$0.34-2.41%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -28.93% | 113.82% | -198.04% | 37.80% | -73.91% |
| Total Depreciation and Amortization | 153.12% | -295.50% | -5.95% | -2.74% | -1.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -131.78% | -33.31% | 2,395.31% | -92.63% | 500.12% |
| Change in Net Operating Assets | -514.27% | 219.61% | 80.56% | 45.41% | -254.89% |
| Cash from Operations | -154.53% | -30.58% | 79.47% | -30.79% | -64.84% |
| Capital Expenditure | -64.39% | 28.28% | -5.27% | -94.61% | 43.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4,273.98% | 34.01% | 36.40% | 90.45% | 78.15% |
| Cash from Investing | -990.40% | 29.62% | 8.76% | 74.14% | 76.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -56.63% | -- |
| Repurchase of Common Stock | 50.00% | 87.50% | 98.04% | -8,070.00% | 90.91% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 100.00% | 75.00% | 99.44% | 96.05% | 0.36% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 66.67% | 85.00% | 98.66% | 91.67% | 1.37% |
| Foreign Exchange rate Adjustments | -100.00% | -85.71% | 86.67% | 107.61% | -857.69% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -434.37% | -30.86% | 247.90% | 116.55% | 47.16% |
